"The Sanford Project: T-Rex Study", a collaborative study between Sanford Health and Caladrius Biosciences, Inc., for adolescents with newly onset type 1 diabetes has examined the body's ability to type fight 1 diabetes using cell therapy on its first participant.
Type 1 diabetes, an autoimmune disease characterized by a loss of insulin-producing beta cells, is the focus of The Sanford Project, a cornerstone research initiative at Sanford Research.
To Identify Targets for Treatment of Insulin Resistance and Diabetes Sanford-Burnham Collaborates With Pfizer
Sanford-Burnham Medical Research Institute (Sanford-Burnham) announced that it has entered into a collaboration with Pfizer Inc.
Advertisement
‘The Sanford Project has enrolled its first patient for conducting the clinical trial on a cell therapy using regulatory T cells, or Treg cells to treat type 1 diabetes.
’
Tweet it Now
Investigators in this trial are studying the effectiveness of cell therapy with expanded regulatory T cells, or Treg cells, to treat type 1 diabetes. Treg cells regulate the body's immune system. A participant's own Treg cells are extracted from the body, purified and multiplied and returned to blood circulation. Researchers are monitoring if beta cells and insulin production can be preserved through this type of immunotherapy.
"The enrollment of the first patient in The Sanford Project: T-Rex Study demonstrates Sanford''s commitment to bringing cutting-edge research and next generation treatments to our region." said Kurt Griffin, director of clinical trials for The Sanford Project. "Leveraging the body's own natural mechanisms is a particularly appealing approach."
Participants in The Sanford Project: T-Rex Study must be 12 to 17 years old and have been diagnosed with diabetes in approximately the last two months.
Source: Newswise
Participants in The Sanford Project: T-Rex Study must be 12 to 17 years old and have been diagnosed with diabetes in approximately the last two months.
Source: Newswise
Diabetes is the No. 1 Reason for Kidney Damage: Health Experts
Ninety percent of people in developing countries consider diabetes to be a trivial disease, which can be controlled throughout their lives on insulin dose.
Advertisement
 Ixmyelocel-T Therapy Shows Promise Against End-Stage Heart FailureEnd-stage heart failure is a condition where the heart fails to pump enough blood. A heart pumping machine is usually given to patients as a temporary measure. | Advertisement
|
California-Based Company to Roll Out World’s First Stem Cell Therapy On Parkinson’s Disease
The company has received approval for conducting a clinical trial of stem cell therapy in patients affected with mild to severe Parkinson's disease.
Advertisement
Recommended Reading
Latest Diabetes News
A new smartphone app or support tool developed helps improve mental health in individuals with type 1 diabetes.
Type 2 diabetes mice injected with beta cells with increased CD63 protein marker production had their blood sugar levels restored to normal.
Good news to children with diabetes: New artificial pancreas can help improve blood sugar control in kids.
New study reveals the link between pre-sleep light exposure and gestational diabetes mellitus in pregnant women.
Spinal cord stimulation delivers electrical stimulation to the spinal cord to cut off pain signals to the brain and may ease pain associated with diabetic neuropathy.